nodes	percent_of_prediction	percent_of_DWPC	metapath
Terbutaline—Hypertonia—Rosuvastatin—atherosclerosis	0.0235	0.0334	CcSEcCtD
Terbutaline—Hypertonia—Niacin—atherosclerosis	0.0171	0.0243	CcSEcCtD
Terbutaline—Cramp muscle—Lovastatin—atherosclerosis	0.0149	0.0211	CcSEcCtD
Terbutaline—Cramp muscle—Ezetimibe—atherosclerosis	0.0146	0.0207	CcSEcCtD
Terbutaline—Cramp muscle—Simvastatin—atherosclerosis	0.0139	0.0197	CcSEcCtD
Terbutaline—Cramp muscle—Pravastatin—atherosclerosis	0.0126	0.0178	CcSEcCtD
Terbutaline—Flushing—Lovastatin—atherosclerosis	0.0106	0.015	CcSEcCtD
Terbutaline—Sweating—Niacin—atherosclerosis	0.0105	0.0149	CcSEcCtD
Terbutaline—Flushing—Ezetimibe—atherosclerosis	0.0104	0.0148	CcSEcCtD
Terbutaline—Flushing—Simvastatin—atherosclerosis	0.00992	0.0141	CcSEcCtD
Terbutaline—Muscle spasms—Lovastatin—atherosclerosis	0.00956	0.0136	CcSEcCtD
Terbutaline—Muscle spasms—Ezetimibe—atherosclerosis	0.00938	0.0133	CcSEcCtD
Terbutaline—Tremor—Lovastatin—atherosclerosis	0.00932	0.0132	CcSEcCtD
Terbutaline—Flushing—Niacin—atherosclerosis	0.0091	0.0129	CcSEcCtD
Terbutaline—Flushing—Pravastatin—atherosclerosis	0.00896	0.0127	CcSEcCtD
Terbutaline—Muscle spasms—Simvastatin—atherosclerosis	0.00894	0.0127	CcSEcCtD
Terbutaline—Tremor—Simvastatin—atherosclerosis	0.00871	0.0124	CcSEcCtD
Terbutaline—Insomnia—Rosuvastatin—atherosclerosis	0.00866	0.0123	CcSEcCtD
Terbutaline—Palpitations—Ezetimibe—atherosclerosis	0.00862	0.0122	CcSEcCtD
Terbutaline—Paraesthesia—Rosuvastatin—atherosclerosis	0.0086	0.0122	CcSEcCtD
Terbutaline—Chest pain—Lovastatin—atherosclerosis	0.00847	0.012	CcSEcCtD
Terbutaline—Anxiety—Lovastatin—atherosclerosis	0.00844	0.012	CcSEcCtD
Terbutaline—Tension—Niacin—atherosclerosis	0.00838	0.0119	CcSEcCtD
Terbutaline—Chest pain—Ezetimibe—atherosclerosis	0.0083	0.0118	CcSEcCtD
Terbutaline—Nervousness—Niacin—atherosclerosis	0.00829	0.0118	CcSEcCtD
Terbutaline—Dry mouth—Lovastatin—atherosclerosis	0.00828	0.0118	CcSEcCtD
Terbutaline—Tension—Pravastatin—atherosclerosis	0.00825	0.0117	CcSEcCtD
Terbutaline—Muscle spasms—Niacin—atherosclerosis	0.00821	0.0117	CcSEcCtD
Terbutaline—Nervousness—Pravastatin—atherosclerosis	0.00817	0.0116	CcSEcCtD
Terbutaline—Dry mouth—Ezetimibe—atherosclerosis	0.00812	0.0115	CcSEcCtD
Terbutaline—Muscle spasms—Pravastatin—atherosclerosis	0.00808	0.0115	CcSEcCtD
Terbutaline—Clenbuterol—TNF—atherosclerosis	0.008	0.704	CrCbGaD
Terbutaline—Chest pain—Simvastatin—atherosclerosis	0.00792	0.0112	CcSEcCtD
Terbutaline—Anxiety—Simvastatin—atherosclerosis	0.00789	0.0112	CcSEcCtD
Terbutaline—Tremor—Pravastatin—atherosclerosis	0.00788	0.0112	CcSEcCtD
Terbutaline—Palpitations—Niacin—atherosclerosis	0.00755	0.0107	CcSEcCtD
Terbutaline—Insomnia—Lovastatin—atherosclerosis	0.00734	0.0104	CcSEcCtD
Terbutaline—Paraesthesia—Lovastatin—atherosclerosis	0.00729	0.0103	CcSEcCtD
Terbutaline—Dyspnoea—Lovastatin—atherosclerosis	0.00723	0.0103	CcSEcCtD
Terbutaline—Insomnia—Ezetimibe—atherosclerosis	0.0072	0.0102	CcSEcCtD
Terbutaline—Chest pain—Pravastatin—atherosclerosis	0.00716	0.0102	CcSEcCtD
Terbutaline—Paraesthesia—Ezetimibe—atherosclerosis	0.00715	0.0101	CcSEcCtD
Terbutaline—Anxiety—Pravastatin—atherosclerosis	0.00713	0.0101	CcSEcCtD
Terbutaline—Dry mouth—Niacin—atherosclerosis	0.00711	0.0101	CcSEcCtD
Terbutaline—Dyspnoea—Ezetimibe—atherosclerosis	0.0071	0.0101	CcSEcCtD
Terbutaline—Asthenia—Rosuvastatin—atherosclerosis	0.00687	0.00975	CcSEcCtD
Terbutaline—Insomnia—Simvastatin—atherosclerosis	0.00687	0.00975	CcSEcCtD
Terbutaline—Paraesthesia—Simvastatin—atherosclerosis	0.00682	0.00968	CcSEcCtD
Terbutaline—Tachycardia—Niacin—atherosclerosis	0.0068	0.00966	CcSEcCtD
Terbutaline—Dyspnoea—Simvastatin—atherosclerosis	0.00677	0.00961	CcSEcCtD
Terbutaline—Hyperhidrosis—Niacin—atherosclerosis	0.00674	0.00957	CcSEcCtD
Terbutaline—Hyperhidrosis—Pravastatin—atherosclerosis	0.00663	0.00942	CcSEcCtD
Terbutaline—Dizziness—Rosuvastatin—atherosclerosis	0.00633	0.00899	CcSEcCtD
Terbutaline—Insomnia—Niacin—atherosclerosis	0.0063	0.00895	CcSEcCtD
Terbutaline—Paraesthesia—Niacin—atherosclerosis	0.00626	0.00888	CcSEcCtD
Terbutaline—Dyspnoea—Niacin—atherosclerosis	0.00621	0.00882	CcSEcCtD
Terbutaline—Insomnia—Pravastatin—atherosclerosis	0.00621	0.00881	CcSEcCtD
Terbutaline—Somnolence—Niacin—atherosclerosis	0.0062	0.0088	CcSEcCtD
Terbutaline—Paraesthesia—Pravastatin—atherosclerosis	0.00616	0.00875	CcSEcCtD
Terbutaline—Dyspnoea—Pravastatin—atherosclerosis	0.00612	0.00869	CcSEcCtD
Terbutaline—Rash—Rosuvastatin—atherosclerosis	0.00604	0.00857	CcSEcCtD
Terbutaline—Dermatitis—Rosuvastatin—atherosclerosis	0.00603	0.00856	CcSEcCtD
Terbutaline—Headache—Rosuvastatin—atherosclerosis	0.006	0.00852	CcSEcCtD
Terbutaline—Asthenia—Lovastatin—atherosclerosis	0.00582	0.00827	CcSEcCtD
Terbutaline—Asthenia—Ezetimibe—atherosclerosis	0.00571	0.00811	CcSEcCtD
Terbutaline—Nausea—Rosuvastatin—atherosclerosis	0.00569	0.00807	CcSEcCtD
Terbutaline—Asthenia—Simvastatin—atherosclerosis	0.00545	0.00773	CcSEcCtD
Terbutaline—Dizziness—Lovastatin—atherosclerosis	0.00537	0.00762	CcSEcCtD
Terbutaline—Dizziness—Ezetimibe—atherosclerosis	0.00526	0.00747	CcSEcCtD
Terbutaline—Vomiting—Lovastatin—atherosclerosis	0.00516	0.00733	CcSEcCtD
Terbutaline—Rash—Lovastatin—atherosclerosis	0.00512	0.00726	CcSEcCtD
Terbutaline—Dermatitis—Lovastatin—atherosclerosis	0.00511	0.00726	CcSEcCtD
Terbutaline—Headache—Lovastatin—atherosclerosis	0.00508	0.00722	CcSEcCtD
Terbutaline—Vomiting—Ezetimibe—atherosclerosis	0.00506	0.00718	CcSEcCtD
Terbutaline—Dizziness—Simvastatin—atherosclerosis	0.00502	0.00713	CcSEcCtD
Terbutaline—Rash—Ezetimibe—atherosclerosis	0.00502	0.00712	CcSEcCtD
Terbutaline—Dermatitis—Ezetimibe—atherosclerosis	0.00501	0.00712	CcSEcCtD
Terbutaline—Asthenia—Niacin—atherosclerosis	0.005	0.0071	CcSEcCtD
Terbutaline—Headache—Ezetimibe—atherosclerosis	0.00499	0.00708	CcSEcCtD
Terbutaline—Asthenia—Pravastatin—atherosclerosis	0.00492	0.00699	CcSEcCtD
Terbutaline—Vomiting—Simvastatin—atherosclerosis	0.00483	0.00685	CcSEcCtD
Terbutaline—Nausea—Lovastatin—atherosclerosis	0.00482	0.00684	CcSEcCtD
Terbutaline—Rash—Simvastatin—atherosclerosis	0.00479	0.00679	CcSEcCtD
Terbutaline—Dermatitis—Simvastatin—atherosclerosis	0.00478	0.00679	CcSEcCtD
Terbutaline—Headache—Simvastatin—atherosclerosis	0.00476	0.00675	CcSEcCtD
Terbutaline—Nausea—Ezetimibe—atherosclerosis	0.00473	0.00671	CcSEcCtD
Terbutaline—Dizziness—Niacin—atherosclerosis	0.00461	0.00654	CcSEcCtD
Terbutaline—Dizziness—Pravastatin—atherosclerosis	0.00454	0.00644	CcSEcCtD
Terbutaline—Nausea—Simvastatin—atherosclerosis	0.00451	0.0064	CcSEcCtD
Terbutaline—Vomiting—Niacin—atherosclerosis	0.00443	0.00629	CcSEcCtD
Terbutaline—Rash—Niacin—atherosclerosis	0.00439	0.00624	CcSEcCtD
Terbutaline—Dermatitis—Niacin—atherosclerosis	0.00439	0.00623	CcSEcCtD
Terbutaline—Headache—Niacin—atherosclerosis	0.00437	0.0062	CcSEcCtD
Terbutaline—Vomiting—Pravastatin—atherosclerosis	0.00436	0.00619	CcSEcCtD
Terbutaline—Rash—Pravastatin—atherosclerosis	0.00433	0.00614	CcSEcCtD
Terbutaline—Dermatitis—Pravastatin—atherosclerosis	0.00432	0.00614	CcSEcCtD
Terbutaline—Headache—Pravastatin—atherosclerosis	0.0043	0.0061	CcSEcCtD
Terbutaline—Nausea—Niacin—atherosclerosis	0.00414	0.00588	CcSEcCtD
Terbutaline—Nausea—Pravastatin—atherosclerosis	0.00408	0.00579	CcSEcCtD
Terbutaline—Epinephrine—TNF—atherosclerosis	0.00336	0.296	CrCbGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—LDLRAP1—atherosclerosis	0.00182	0.00639	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—PLTP—atherosclerosis	0.00171	0.00601	CbGpPWpGaD
Terbutaline—BCHE—Peptide hormone metabolism—AGT—atherosclerosis	0.00168	0.00593	CbGpPWpGaD
Terbutaline—BCHE—Peptide hormone metabolism—LEP—atherosclerosis	0.00165	0.00581	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—HRH1—atherosclerosis	0.00155	0.00546	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—LTA4H—atherosclerosis	0.00148	0.00521	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—ABCG8—atherosclerosis	0.00148	0.00521	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL4—atherosclerosis	0.00147	0.00519	CbGpPWpGaD
Terbutaline—ADRB2—GPCRs, Class A Rhodopsin-like—CX3CR1—atherosclerosis	0.00147	0.00517	CbGpPWpGaD
Terbutaline—BCHE—Peptide hormone metabolism—INS—atherosclerosis	0.00141	0.00496	CbGpPWpGaD
Terbutaline—ADRB2—GPCRs, Class A Rhodopsin-like—CNR2—atherosclerosis	0.00137	0.00481	CbGpPWpGaD
Terbutaline—BCHE—Peptide hormone metabolism—IGF1—atherosclerosis	0.00136	0.0048	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—UTS2—atherosclerosis	0.00131	0.00462	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—CX3CR1—atherosclerosis	0.00126	0.00443	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—CX3CL1—atherosclerosis	0.00124	0.00435	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—CNR2—atherosclerosis	0.00117	0.00412	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	0.00117	0.00412	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—CCL4—atherosclerosis	0.00112	0.00395	CbGpPWpGaD
Terbutaline—ADRB2—Calcium Regulation in the Cardiac Cell—PRKCG—atherosclerosis	0.00112	0.00395	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	0.0011	0.00387	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	0.0011	0.00387	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	0.00108	0.0038	CbGpPWpGaD
Terbutaline—ADRB2—GPCRs, Class A Rhodopsin-like—CCR2—atherosclerosis	0.00106	0.00374	CbGpPWpGaD
Terbutaline—ADRB2—GPCRs, Class A Rhodopsin-like—EDNRA—atherosclerosis	0.00106	0.00374	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	0.00106	0.00374	CbGpPWpGaD
Terbutaline—BCHE—Phospholipid metabolism—PIK3CG—atherosclerosis	0.00101	0.00356	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL3—atherosclerosis	0.00101	0.00354	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—UTS2—atherosclerosis	0.001	0.00352	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	0.000981	0.00345	CbGpPWpGaD
Terbutaline—BCHE—Transmission across Chemical Synapses—PRKCG—atherosclerosis	0.000966	0.0034	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—CX3CR1—atherosclerosis	0.00096	0.00338	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—CASR—atherosclerosis	0.00096	0.00338	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—CX3CL1—atherosclerosis	0.000941	0.00331	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	0.00093	0.00327	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	0.00093	0.00327	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	0.00093	0.00327	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	0.00093	0.00327	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	0.000919	0.00323	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDNRA—atherosclerosis	0.000911	0.00321	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR2—atherosclerosis	0.000911	0.00321	CbGpPWpGaD
Terbutaline—ADRB2—GPCRs, Class A Rhodopsin-like—AGTR1—atherosclerosis	0.000904	0.00318	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—CNR2—atherosclerosis	0.000892	0.00314	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—GHRL—atherosclerosis	0.000888	0.00312	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	0.000888	0.00312	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—PLA2G7—atherosclerosis	0.000887	0.00312	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—HRH1—atherosclerosis	0.000878	0.00309	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	0.000851	0.00299	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	0.000819	0.00288	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—LDLRAP1—atherosclerosis	0.000809	0.00285	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—HRH1—atherosclerosis	0.000797	0.0028	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	0.000791	0.00278	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—KNG1—atherosclerosis	0.000779	0.00274	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGTR1—atherosclerosis	0.000775	0.00273	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—CCL3—atherosclerosis	0.000767	0.0027	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PLTP—atherosclerosis	0.000761	0.00268	CbGpPWpGaD
Terbutaline—BCHE—Neuronal System—PRKCG—atherosclerosis	0.00074	0.0026	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—HSPD1—atherosclerosis	0.000721	0.00254	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	0.000705	0.00248	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	0.000701	0.00247	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	0.000696	0.00245	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—EDNRA—atherosclerosis	0.000694	0.00244	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—CCR2—atherosclerosis	0.000694	0.00244	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	0.00068	0.00239	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—GHRL—atherosclerosis	0.000676	0.00238	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—ABCG8—atherosclerosis	0.00066	0.00232	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—LTA4H—atherosclerosis	0.00066	0.00232	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDN1—atherosclerosis	0.000657	0.00231	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL5—atherosclerosis	0.000652	0.00229	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	0.000651	0.00229	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	0.000615	0.00216	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—KNG1—atherosclerosis	0.000593	0.00209	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—AGTR1—atherosclerosis	0.00059	0.00208	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—F7—atherosclerosis	0.000581	0.00204	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—CCL4—atherosclerosis	0.000576	0.00203	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—UTS2—atherosclerosis	0.000566	0.00199	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	0.000548	0.00193	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGT—atherosclerosis	0.000545	0.00192	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—CASR—atherosclerosis	0.000542	0.00191	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—ABCG1—atherosclerosis	0.000522	0.00183	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—GHRL—atherosclerosis	0.000518	0.00182	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—UTS2—atherosclerosis	0.000514	0.00181	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—CNR2—atherosclerosis	0.000504	0.00177	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—F2—atherosclerosis	0.000504	0.00177	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—ACE—atherosclerosis	0.000502	0.00177	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—EDN1—atherosclerosis	0.0005	0.00176	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—CCL5—atherosclerosis	0.000496	0.00175	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—CX3CR1—atherosclerosis	0.000492	0.00173	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—CASR—atherosclerosis	0.000492	0.00173	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—FABP4—atherosclerosis	0.00049	0.00173	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—LCAT—atherosclerosis	0.00049	0.00173	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—CX3CL1—atherosclerosis	0.000483	0.0017	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—APOA4—atherosclerosis	0.000481	0.00169	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CYP7A1—atherosclerosis	0.000473	0.00166	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—HRH1—atherosclerosis	0.000471	0.00166	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—CNR2—atherosclerosis	0.000458	0.00161	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—PLAUR—atherosclerosis	0.000451	0.00159	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	0.000451	0.00159	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	0.000449	0.00158	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—PLG—atherosclerosis	0.00044	0.00155	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CYP27A1—atherosclerosis	0.000437	0.00154	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	0.00043	0.00151	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	0.00042	0.00148	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—AGT—atherosclerosis	0.000415	0.00146	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—ALOX5AP—atherosclerosis	0.000414	0.00146	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—ALOX15—atherosclerosis	0.000414	0.00146	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PLA2G2A—atherosclerosis	0.000414	0.00146	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—APOA2—atherosclerosis	0.000414	0.00146	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—ABCG5—atherosclerosis	0.000409	0.00144	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	0.000409	0.00144	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—IGF2—atherosclerosis	0.000401	0.00141	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—LPA—atherosclerosis	0.000395	0.00139	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—CCL3—atherosclerosis	0.000394	0.00139	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—CCR2—atherosclerosis	0.000392	0.00138	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—EDNRA—atherosclerosis	0.000392	0.00138	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—F2—atherosclerosis	0.000384	0.00135	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—BGN—atherosclerosis	0.000383	0.00135	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—GHRL—atherosclerosis	0.000382	0.00134	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	0.00038	0.00134	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—APOA5—atherosclerosis	0.000379	0.00133	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—APOA4—atherosclerosis	0.00037	0.0013	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	0.000368	0.0013	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PLA2G1B—atherosclerosis	0.000365	0.00128	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	0.000361	0.00127	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	0.000357	0.00126	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	0.000357	0.00125	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—EDNRA—atherosclerosis	0.000356	0.00125	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—CCR2—atherosclerosis	0.000356	0.00125	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.000355	0.00125	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—ALOX5—atherosclerosis	0.000352	0.00124	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—GHRL—atherosclerosis	0.000347	0.00122	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—CCL2—atherosclerosis	0.000342	0.0012	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CCL4—atherosclerosis	0.00034	0.0012	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—KNG1—atherosclerosis	0.000335	0.00118	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—AGTR1—atherosclerosis	0.000333	0.00117	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	0.000326	0.00115	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—MMP1—atherosclerosis	0.000322	0.00113	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—APOA2—atherosclerosis	0.000318	0.00112	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—AGT—atherosclerosis	0.000318	0.00112	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—NAMPT—atherosclerosis	0.000316	0.00111	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	0.000314	0.00111	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—LIPC—atherosclerosis	0.000314	0.0011	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—APOC3—atherosclerosis	0.000312	0.0011	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—LEP—atherosclerosis	0.000312	0.0011	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—LDLR—atherosclerosis	0.00031	0.00109	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—KNG1—atherosclerosis	0.000305	0.00107	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—UTS2—atherosclerosis	0.000303	0.00107	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CETP—atherosclerosis	0.000303	0.00107	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—AGTR1—atherosclerosis	0.000303	0.00107	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—F2—atherosclerosis	0.000294	0.00103	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CX3CR1—atherosclerosis	0.000291	0.00102	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CASR—atherosclerosis	0.000291	0.00102	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—SCARB1—atherosclerosis	0.00029	0.00102	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CX3CL1—atherosclerosis	0.000285	0.001	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—EDN1—atherosclerosis	0.000283	0.000994	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	0.000282	0.000994	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—CCL5—atherosclerosis	0.00028	0.000987	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—HMGCR—atherosclerosis	0.000274	0.000964	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CNR2—atherosclerosis	0.00027	0.000952	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—CXCL8—atherosclerosis	0.00027	0.000951	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—MMP3—atherosclerosis	0.00027	0.000949	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—PRKCG—atherosclerosis	0.000267	0.000938	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—INS—atherosclerosis	0.000266	0.000937	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—CCL2—atherosclerosis	0.000262	0.000922	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—IGF1—atherosclerosis	0.000258	0.000906	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—EDN1—atherosclerosis	0.000257	0.000903	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—CCL5—atherosclerosis	0.000255	0.000896	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—MMP2—atherosclerosis	0.000249	0.000877	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	0.000247	0.000869	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—ABCA1—atherosclerosis	0.000244	0.000859	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—PRKCG—atherosclerosis	0.000242	0.000852	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—VWF—atherosclerosis	0.000241	0.000848	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—APOC3—atherosclerosis	0.00024	0.000843	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—LDLR—atherosclerosis	0.000238	0.000838	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—AGT—atherosclerosis	0.000235	0.000825	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CCL3—atherosclerosis	0.000233	0.000818	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—NCF1—atherosclerosis	0.000223	0.000784	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—F2—atherosclerosis	0.000217	0.000763	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—AGT—atherosclerosis	0.000213	0.00075	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CCR2—atherosclerosis	0.00021	0.00074	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—EDNRA—atherosclerosis	0.00021	0.00074	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—HMOX1—atherosclerosis	0.00021	0.000737	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CYBA—atherosclerosis	0.000209	0.000737	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000207	0.00073	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—CXCL8—atherosclerosis	0.000207	0.000729	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—GHRL—atherosclerosis	0.000205	0.000721	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PARP1—atherosclerosis	0.000205	0.000721	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PLAT—atherosclerosis	0.000205	0.000721	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—APOB—atherosclerosis	0.000201	0.000706	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—F2—atherosclerosis	0.000197	0.000693	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—GSTM1—atherosclerosis	0.000195	0.000687	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—LPL—atherosclerosis	0.000192	0.000674	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—PIK3CG—atherosclerosis	0.000188	0.000663	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—GPX1—atherosclerosis	0.000187	0.000658	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CD36—atherosclerosis	0.000182	0.000641	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—KNG1—atherosclerosis	0.00018	0.000633	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—AGTR1—atherosclerosis	0.000179	0.000629	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—CCL2—atherosclerosis	0.000175	0.000617	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PLG—atherosclerosis	0.000174	0.000613	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—MTHFR—atherosclerosis	0.000173	0.000607	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PPARA—atherosclerosis	0.000169	0.000596	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—SOCS3—atherosclerosis	0.000165	0.000581	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—AGT—atherosclerosis	0.000164	0.000577	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—APOE—atherosclerosis	0.000161	0.000565	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—MMP3—atherosclerosis	0.000159	0.000561	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CAV1—atherosclerosis	0.000159	0.00056	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—APOA1—atherosclerosis	0.000159	0.000559	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—IGF2—atherosclerosis	0.000159	0.000558	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—APOB—atherosclerosis	0.000154	0.000542	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—CXCL8—atherosclerosis	0.000153	0.000537	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—EDN1—atherosclerosis	0.000152	0.000533	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CCL5—atherosclerosis	0.00015	0.000529	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—LPL—atherosclerosis	0.000147	0.000518	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PIK3CG—atherosclerosis	0.000145	0.00051	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PRKCG—atherosclerosis	0.000143	0.000503	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PPARG—atherosclerosis	0.00014	0.000492	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—SPP1—atherosclerosis	0.000139	0.00049	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—CXCL8—atherosclerosis	0.000139	0.000488	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—INS—atherosclerosis	0.000137	0.000483	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PDGFB—atherosclerosis	0.000129	0.000454	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—AGT—atherosclerosis	0.000126	0.000443	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—ALB—atherosclerosis	0.000126	0.000443	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—LEP—atherosclerosis	0.000123	0.000434	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—APOE—atherosclerosis	0.000123	0.000434	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CAV1—atherosclerosis	0.000122	0.00043	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—APOA1—atherosclerosis	0.000122	0.000429	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—NOS3—atherosclerosis	0.00012	0.000423	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—ESR1—atherosclerosis	0.000118	0.000414	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—F2—atherosclerosis	0.000116	0.000409	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PIK3CG—atherosclerosis	0.000111	0.000392	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PTGS2—atherosclerosis	0.00011	0.000387	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—MAPK3—atherosclerosis	0.000107	0.000375	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—INS—atherosclerosis	0.000105	0.000371	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CCL2—atherosclerosis	0.000104	0.000365	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—IGF1—atherosclerosis	0.000102	0.000358	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—SERPINE1—atherosclerosis	9.68e-05	0.00034	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—NOS3—atherosclerosis	9.24e-05	0.000325	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CXCL8—atherosclerosis	8.19e-05	0.000288	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—AKT1—atherosclerosis	7.92e-05	0.000279	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—IL6—atherosclerosis	7.79e-05	0.000274	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—MMP9—atherosclerosis	7.41e-05	0.000261	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—NFKB1—atherosclerosis	7.33e-05	0.000258	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—MAPK8—atherosclerosis	7.21e-05	0.000254	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—AKT1—atherosclerosis	7.19e-05	0.000253	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—VEGFA—atherosclerosis	6.66e-05	0.000234	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—STAT3—atherosclerosis	6.59e-05	0.000232	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—MAPK3—atherosclerosis	6.3e-05	0.000222	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—TGFB1—atherosclerosis	6.11e-05	0.000215	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—AKT1—atherosclerosis	5.53e-05	0.000195	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—IL6—atherosclerosis	4.6e-05	0.000162	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—AKT1—atherosclerosis	4.25e-05	0.000149	CbGpPWpGaD
